Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. Issue 5 (25th July 2014)

• Record Type: Journal Article
• Authors: Lamming, Dudley W.; Mihaylova, Maria M.; Katajisto, Pekka; Baar, Emma L.; Yilmaz, Omer H.; Hutchins, Amanda; Gultekin, Yetis; Gaither, Rachel; Sabatini, David M.
• Is Part Of: Aging cell. Volume 13:Issue 5(2014:Oct.)
• Page Start: 911
• Page End: 917
• Publication Date: 2014-07-25
• Subjects: Cells -- Aging -- Periodicals; 571.8783605
• DOI: 10.1111/acel.12256
• Languages: English
• ISSNs: 1474-9718

Abstract

<abstract abstract-type="main" id="acel12256-abs-0001"> <title>Summary</title> <p>Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR), robustly extends the lifespan of model organisms including mice. We recently found that chronic treatment with rapamycin not only inhibits mTOR complex 1 (mTORC1), the canonical target of rapamycin, but also inhibits mTOR complex 2 (mTORC2) <italic>in vivo</italic>. While genetic evidence strongly suggests that inhibition of mTORC1 is sufficient to promote longevity, the impact of mTORC2 inhibition on mammalian longevity has not been assessed. RICTOR is a protein component of mTORC2 that is essential for its activity. We examined three different mouse models of <italic>Rictor</italic> loss: mice heterozygous for <italic>Rictor</italic>, mice lacking hepatic <italic>Rictor</italic>, and mice in which <italic>Rictor</italic> was inducibly deleted throughout the body in adult animals. Surprisingly, we find that depletion of RICTOR significantly decreases male, but not female, lifespan. While the mechanism by which RICTOR loss impairs male survival remains obscure, we find that the effect of RICTOR depletion on lifespan is independent of the role of hepatic mTORC2 in promoting glucose tolerance. Our results suggest that inhibition of mTORC2 signaling is detrimental to males, which may explain in part why interventions that decrease mTOR signaling show greater efficacy in females.</p> </abstract>